COVID-19 vaccine verdicts loom as next big market risk

  • 📰 Reuters
  • ⏱ Reading Time:
  • 14 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 9%
  • Publisher: 97%

مصر أخبار أخبار

مصر أحدث الأخبار,مصر عناوين

Optimism that vaccines are on the way to end the coronavirus pandemic has been a major factor in this year’s U.S. stock resurgence. That will face a critical test in coming weeks, as investors await clinical data on whether they actually work.

possible as soon as October or November. Disappointing results could further shake markets that have recently grown turbulent on worries over fiscal stimulus delays and uncertainty around the Nov. 3 U.S. presidential election.

The number of vaccines in development could blunt the negative market impact of any single setback. More than a half-dozen vaccines globally are in late-stage trials out of over 30 currently being tested in humans, according to the World Health Organization.

لقد قمنا بتلخيص هذا الخبر حتى تتمكن من قراءته بسرعة. إذا كنت مهتمًا بالأخبار، يمكنك قراءة النص الكامل هنا. اقرأ أكثر:

 /  🏆 2. in EG
 

شكرًا لك على تعليقك. سيتم نشر تعليقك بعد مراجعته.

Why still use archaic buildings with screens everywhere? Why not use the internet?

All the data about vaccine timelines, about vaccine Innovation. In one handy White House report. Mitigating the impact of pandemic influenza through vaccine Innovation. From Sept 15th 2019.

Why is the entire English speaking media peddling a vax we will never have or need.

مصر أحدث الأخبار, مصر عناوين